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Abstracts / Urological Science 26 (2015) S36eS49 S41urinary symptoms such as frequency, urgency, and nocturia. Previous
study reported that patients with IC/BPS during the 3-year follow-up
period showed increased risk of bladder cancer than healthy controls.
However, a potential detection bias may exist when elevated risk for
bladder cancer within three years immediately following an IC/BPS diag-
nosis. There should be noted that it is also common for IC/BPS to coexist
with either unexplained medical conditions, such as ﬁbromyalgia, irritable
bowel syndrome, and chronic fatigue syndrome or confusable diseases
during diagnosis of IC/BPS, such as urolithiasis and urinary tract infection.
Therefore, we re-examined the risk of bladder cancer in a large population
based cohort of individuals with a new diagnosis of IC/BPS to assess a
potential detection bias.
Materials and methods: We performed a retrospective cohort study of
Longitudinal Health Insurance Database 2000 with newly diagnosis of IC/
BPS from 2002 through 2010. After limiting our sample to patients with IC/
BPS diagnosis (ICD-9 code 595.1 at least once during the study period), we
identiﬁed an IC/BPS cohort. We then excluded patients with diagnosis of
bladder cancer (ICD-9 codes, 180-189) before IC/BPS diagnosis. The pri-
mary outcome was the event of bladder cancer, determined by the record
with ICD-9 codes, 180-189 after the entry dates. We deﬁned the logit of
predicted probability of bladder cancer as a propensity score using the
following baseline characteristics: sex, age, date of diagnosis, comorbidity,
and smoking status. Subjects with IC/BPS were matched on a one-to one
basis with subjects with non-IC/BPS. We used chi-square tests to evaluate
associations between events of bladder cancer and patient-level covariates
(age, sex, comorbidity, smoking status). Next, we compared primary
outcome (events of bladder cancer) between IC/BPS and non-IC/BPS cohort
using multiple logistic regression. Analyses were performed using SPSS
version 22.
Results: After adjusted with propensity score-matching, we identiﬁed
1642 patients with diagnosis of IC/BPS and 1642 patients with non-IC/BPS
cohort. There is no statistically signiﬁcant association between comor-
bidity and bladder cancer except urolithiasis (P < 0.001) and urinary tract
infection (P ¼ 0.03). During the study period, 20 (1.2%) IC/BPS patients and
30 (1.8%) non-IC/BPS patients were diagnosed as having bladder cancer.
Chi-square test showed no difference of bladder cancer incidence between
IC/BPS and non-IC/BPS cohort (p ¼ 0.2). Moreover, the multiple logistic
regressions estimating the risk of bladder cancer showed no signiﬁcant
association among IC/BPS, sex, urolithiasis, and urinary tract infection
except age (B ¼ 0.02, p ¼ 0.005).
Conclusions: Our results imply us that IC/BPS is not related to bladder
cancer. The detection bias from previous study may be the results of either
an inadequate matching non-IC/BPS cohort or poor controlled confound-
ing factor.Moderated Poster-3Urolithiasis
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COMPARISON OF EFFICACY OF URETEROSCOPIC LITHOTRIPSY BETWEEN
PNEUMATIC LITHOCLAST AND HOLMIUM LASER IN MANAGEMENT OF
UPPER URETERAL STONE
Li-Chen Chen, Marcelo Chen, Wun-Rong Lin, Wen-Chou Lin, Huang-Kuang
Chang, Stone Yang, Jong-Ming Hsu, Wei-Kung Tsai, Pai-Kai Chiang, Yung-
Chiong Chow. Department of Urology, Mackay Memorial Hospital, Taipei,
Taiwan
Purpose: To evaluate the efﬁcacy of ureteroscopic lithotripsy with pneu-
matic lithoclast and laser in management of upper ureteral stones.
Materials and methods: We retrospectively review the medical record.
Patients who underwent ureteroscopic lithotripsy by pneumatic lithoclast
and laser between January 2012 to January 2013 for upper ureteral stone in
Mackay Memorial Hospital were included. Cases with concurrent UTI and
acute renal failure were excluded. Invisible stones, loss follow-up or con-
current middle or lower ureteral stones were also excluded. Patient age,
method of lithotripsy, stone size and burden (based on KUB or CT), ureteralcatheter insertion and further ESWL or URSL for residual stone were
recorded.
Results: There were 216 patients identiﬁed. A total of 158 patients met
criteria (118 patients in pneumatic lithoclast group and 40 patients in laser
group). One hundred and seventy-eight ureteral stones (135 in pneumatic
lithoclast group and 43 in laser group respectively) were treated. Themean
age of pneumatic lithoclast and laser group was 53.5years (22-92 years)
and 52.9 years (21-69 years) respectively. The stone size and burden in
both groups were similar (p ¼ 0.44 and 0.45 respectively). There was a
mild trend of better stone free rate and lower secondary intervention rate
in laser group (p¼ 0.07 and p ¼ 0.09 respectively). No severe complication
(>Grade III Clavien classiﬁcation) were observed.
Conclusions: Use of laser lithotripsy in management of upper ureteral
stonewas associatedwith lower rate of ureteral catheter insertion.We also
observed a weak association of better stone free rate and lower secondary
intervention rate in laser lithotripsy group. They were both safe pro-
cedures without major complications.
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DOWE NEED PROPHYLACTIC ANTIBIOTICS PRIOR TO EXTRACORPOREAL
SHOCK WAVE LITHOTRIPSY? A RANDOMIZED CONTROL TRIAL WITH
PROSPECTIVE FOLLOW-UP OF ASSOCIATED COMPLICATIONS
Yin-Buh Liu, Cheng-Hsing Hsieh, Shang-Jen Chang, Chia-Da Lin, Stephan
Yang. Division of Urology, Taipei Tzu Chi Hospital, The Buddhist Tzuchi
Medical Foundation, School of Medicine, Buddhist Tzu-Chi University,
Hualien, Taiwan
Purpose: To compare the efﬁcacy of prophylactic antibiotics in reduction
of post-surgical infections in patients undergoing extracorporeal shock
wave lithotripsy (ESWL).
Materials and methods: The study is a double-blind, prospective, ran-
domized placebo control trial. Between 2012 and 2014, patients with
preoperative sterile urine undergoing ESWL were randomly allocated by
the randomization ratio of 1:1 to receive prophylactic antibiotics with
single-dose oral levoﬂoxacin (500mg) or no treatment (control group),
respectively. Urine analysis and urine cultures were obtained between
postoperative day 5 and 7. Pyuria was deﬁned as S10 WBC/hpf. Signif-
icant bacteriuria was deﬁned as S105cfu uropathogens/ml. Febrile uri-
nary tract infection (fUTI) was deﬁned as body temperature of 38.0
Celsius degree with pyuria or signiﬁcant bacteriuria within 7 days post-
operatively.
Results: Initially, 274 patents underwent randomization with 139 and 135
patients in the control and levoﬂoxacin group, respectively. Finally, 206
patients (106 with placebo and 100 with levoﬂoxacin) with complete
followup of urine analysis were eligible for analysis. The rates of post-
operative pyuria were not signiﬁcantly different in patients with and
without prophylaxis (8% vs. 4.7% p ¼ 0.33). There was also no signiﬁcant
difference in rates of bacteriuria in patients with and without prophylaxis
(0% v.s. 1%, p¼ 0.49). Patients without followup of urine analysis and urine
culture were contacted with telephone and there was only patients with
post-operative fever in the levoﬂoxacin group (0% vs. 0.7%, p ¼ 0.49). As
preliminary results of the interim analysis revealed no beneﬁt of levo-
ﬂoxacin in preventing post-ESWL pyuria, bacteriuria and febrile urinary
tract infection, we terminated the study early before pre-planned sample
size is achieved.
Conclusion: The incidence of asymptomatic and febrile urinary tract
infection is low in patient underwent ESWL with pre-operative sterile
urine. Therefore, prophylactic antibiotics in these patients may be
unnecessary.
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EXPERIENCE OF TUBELESS PERCUTANEOUS NEPHROLITHOTOMY WITH
HEMOSTATIC SEALANT USE
Chi-Chih Lien 1, Yin-Ting Liu 1, Chi-Yun Lan 1, Kai-Yi Tzou 1, Su-Wei
Hu 1, Wei-Tang Kao 1, Kuan-Chou Chen 1,2. 1Department of Urology, Taipei
Medical University-Shuang Ho Hospital, Taipei, Taiwan; 2Department of
Urology, School of Medicine, College of Medicine, Taipei Medical University,
Taiwan
Abstracts / Urological Science 26 (2015) S36eS49S42Purpose: Only few studies in Taiwan showed beneﬁts of tubelss percuta-
neous nephrolithotomy (TPCNL) that were superior to the conventional
percutaneous nephrolithotomy (PCNL). In our study, we would like to
report our experience of performing tubeless PCNLs with hemostatic
sealant (Flosaeal) in ﬁrst 15 patients compare to conventional PCNL. Our
object was to evaluate the safety and beneﬁt of tubeless PCNL with Floseal
use in all patients.
Materials and methods: A retrospective review of the charts of patients
who underwent PCNL at our institute from June 2014 to March 2015 was
performed. The 30F Amplatz sheath system, occlusion balloon catheter,
and Floseal as a sealant were applied to the tubless PCNL group. De-
mographic data, stone characteristics, perioperative course, and compli-
cation rates were collected and assessed.
Results: Out of 62 patients included, 15 patients received tubeless PCNL
while 47 patients received conventional PCNL. There was no difference
between these 2 groups regarding age, gender, BMI, pyuria, number of
stone and stone location. The tubeless PCNL group had higher ASA
(American Society of Anesthesiologists General Classiﬁcation) score
(p ¼ 0.04), shorter hospital stay (p ¼ 0.03), less post-operative pain score
(p ¼ 0.02), less post-operative blood transfusion rate (p ¼ 0.002), less
analgesia used (p ¼ 0.02) and less post-operative fever (p ¼ 0.01), when
compared with conventional group. There were no signiﬁcant differences
in operating time, operative blood loss, stone free rate, decline of hemo-
globin and postoperative ileus between these two groups.
Conclusion: Our report matches the previous reports regarding shorter
hospital stay, less pain, analgesia used and less complication rates in
tubeless PCNL with Floseal use.Laparoscopy
MP3-4.
EXTERNAL VALIDATION OF RENAL NEPHROMETRY SCORE TO ACCESS
THE PERIOPERATIVE PARAMETER FOR LAPAROSCOPIC PARTIAL
NEPHRECTOMY IN A SINGLE INSTITUTION
Chen-Yu Wu1, Yu-Chi Chen 1, Kevin Lu 1, Ching-Yu Huang 1, Henry Y.
Lin 1, Victor C. Lin 1,2. 1Department of Urology, E-Da Hospital, Kaohsiung,
Taiwan; 2 School of Medicine for International Students, I-Shou University,
Kaohsiung, Taiwan
Purpose: RENAL Nephrometry Score (RNS) has been proposed as an
anatomical classiﬁcation system for renal masses to investigate the inﬂu-
ence on perioperative outcomes and complications. The aim of this study
was to assess the system for external validation.
Materials and methods: The single-surgeon database enrolled patients
who had undergone laparoscopic partial nephrectomy by either retro-
peritoneal or transperitoneal approaches from December 2008 to
September 2013, had been proved by IRB. Exclusion criteria is combined
surgery. Renal tumors were categorized by RNS sum score as low (4e6),
intermediate (7e9) and high (10e12). We reviewed peri-operative out-
comes including operation time (OT), length of saty (LOS), estimated blood
loss (EBL), ischemic time, either is cold or warm, need of blood transfusion
during operation. Post-operative complications were categorized by the
modiﬁed Clavien-Dindo classiﬁcation system. The data was collected
retrospective and analyzed by PASW ver. 18.0.
Results: Total 53 patients were enrolled mean age 49.9 ± 13.52. Of the 53
patients, there were 15 low, 26 intermediate and 12 high score lesions.
There was no statistically signiﬁcant difference in the demographics of the
three groups. Total complication rate (22.5% vs 26.6% vs 31.5%; trend
P ¼ 0.017) and grade 3 complication rate (24% vs 26% vs 31%; trend
P ¼ 0.082) had signiﬁcant difference between low, intermediate and high
score groups, respectively. There was no statistic difference in operative
time (trend P ¼ 0.403), ischemia time (19.2 vs 24.9 vs 24.4; trend
P ¼ 0.427), EBL (trend P ¼ 0.883), transfusion rate (trend P ¼ 0.5), and LOS
(trend P ¼ 0.206).
Conclusions: The RNS may categorize tumors based on the technical dif-
ﬁculty of performing LPN when predict complication rate, especially highgrade complications. The others parameters have trend difference but not
achieved statistic difference.
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EFFICACY AND OUTCOME OF TOTAL EXTRAPERITONEAL
HERNIORRHAPHY (TEP) IN PATIENTS WITH RECURRENT INGUINAL
HERNIA
Kai-Yi Tzou 1, Wei-Tang Kao 1, Yi-Te Chiang 1, Chia-Hung Liu 1, Chen-Hsun
Ho 1, Chen Kuan-Chou Chen 1,2, Chia-Chang Wu 1,2. 1Department of
Urology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan;
2Department of Urology, School of Medicine, College of Medicine, Taipei
Medical University, Taipei, Taiwan
Purpose: This study aimed to evaluate the efﬁcacy and outcome of total
extraperitoneal (TEP) herniorrhaphy in patients with recurrent inguinal
hernia.
Methods: Between January 2009 and September 2014, 472 patients un-
derwent TEP herniorrhaphy for inguinal hernia. In this cohort, 38 patients
who ever received previous traditional open herniorrhaphy were deﬁned
as study group. For the comparison group, 76 patients who did not have
previous hernia repair history were randomly selected to match the study
group in terms of age, sex and laterality of inguinal hernia. Perioperative
data including patients' demographics, operative time, pain scale, con-
versions, length of hospital stay, recurrence, and complications were
recorded and analyzed.
Results: In this study, themean follow-up period were 24.5months (7-66).
The operative time in study group and comparison group were 99.7 and
90.2 minutes, respectively (p ¼ 0.8). The pain scale was higher in study
group than that in comparison group, but not signiﬁcant (2.8 vs. 2.3,
p ¼ 0.7). No conversion was needed in both groups. The patients in both
groups could discharge on the ﬁrst postoperative day, without exceptions.
The hernia recurrence rate were similar between study group and com-
parison group (p ¼ 0.7), so as the complication rates (p ¼ 0.2).
Conclusions: TEP herniorrhaphy for patients with recurrent inguinal
hernia is safe and effective. In this study, no signiﬁcant differences were
observed between the two groups in terms of operating time, pain scale,
analgesic use, hospital stay and complications.
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COMPARISON OF LAPAROENDOSCOPIC SINGLE-SITE VERSUS
CONVENTIONAL MULTIPLE-PORT LAPAROSCOPIC HERNIORRHAPHY: A
SYSTEMIC REVIEW AND META-ANALYSIS
Chi-Wen Lo, Shei-Dei Yang, Yao-Chou Tsai, Cheng-Hsing Hsieh, Shang-Jen
Chang. Division of Urology, Department of Surgery, Taipei Tzu-Chi Hospital,
Taiwan
Purpose: We systemically reviewed published literatures and performed
meta-analysis to compare the surgical outcomes between Laparoendo-
scopic single-site over the multiple port total extraperitoneal approach in
hernia repair.
Materials and methods: We performed a systemic search of PubMED®
and Cochrane review for all randomized controlled trials and comparative
trials that compared the efﬁcacy and safety between LESS-TEP andMP-TEP.
The evaluated outcomes included perioperative parameters (operative
time, conversion rate), hospital stay and complications (seroma, delay
return of bladder function, post-operative pain, and recurrence). The
Cochrane Collaboration Review Manager software (RevMan®, Version
5.2.6) was used for statistical analysis.
Results: There were 10 trials met the inclusion criteria and included for
meta-analysis. Totally, there were 595 and 514 patients underwent LESS-
TEP and MP-TEP, respectively. The LESS-TEP took signiﬁcantly longer
operative time than theMP-TEP in unilateral hernia repair (weightedmean
difference (WMD): 4.11minutes, 95% CI¼ 0.76e7.46, p¼ 0.02) while not in
bilateral hernia repair (WMD: 3.87 minutes, 95% of CI: 2.59~10.33,
z ¼ 1.17, p ¼ 0.24). There were no signiﬁcant differences in surgical out-
comes with regard to post-operative pain scale, conversion rate, hospital
